Literature DB >> 11930170

Decreased prefrontal CaMKII alpha mRNA in bipolar illness.

Guoqiang Xing1, Shani Russell, Christopher Hough, Judy O'Grady, Lei Zhang, Shutong Yang, Li-Xin Zhang, Robert Post.   

Abstract

Ca2+/calmodulin-dependent protein kinase II (CaMKII) plays critical roles in neurotransmission, synaptic plasticity, learning and memory. The aim of this study was to examine, by in situ hybridization, prefrontal cortical expression of CaMKII alpha mRNA in postmortem brains of unipolar, bipolar, schizophrenic, and control subjects. Compared to controls, bipolar patients had significantly lower levels of CaMKII alpha mRNA in laminae I-VI of Brodmann's area 9 and laminae I-III and VI of area 46. Unipolar patients also exhibited significantly lower levels of CaMKII alpha mRNA in laminae I-IV of area 9 than did controls. The significant decrease in CaMKII alpha mRNA in bipolar patients could be associated with some of the affective and cognitive alterations that have been linked to prefrontal cortical dysfunction in bipolar disorder, although this requires further direct examination.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11930170     DOI: 10.1097/00001756-200203250-00029

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Differential effect of postnatal lead exposure on gene expression in the hippocampus and frontal cortex.

Authors:  J S Schneider; W Mettil; D W Anderson
Journal:  J Mol Neurosci       Date:  2011-12-10       Impact factor: 3.444

2.  βCaMKII in lateral habenula mediates core symptoms of depression.

Authors:  Kun Li; Tao Zhou; Lujian Liao; Zhongfei Yang; Catherine Wong; Fritz Henn; Roberto Malinow; John R Yates; Hailan Hu
Journal:  Science       Date:  2013-08-30       Impact factor: 47.728

3.  Altered expression of neuroplasticity-related genes in the brain of depressed suicides.

Authors:  B Fuchsova; A Alvarez Juliá; H S Rizavi; A C Frasch; G N Pandey
Journal:  Neuroscience       Date:  2015-04-28       Impact factor: 3.590

4.  Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies.

Authors:  Xue-Qiu Jian; Ke-Sheng Wang; Tie-Jian Wu; Joel J Hillhouse; Jerald E Mullersman
Journal:  J Abnorm Child Psychol       Date:  2011-08

5.  Modulation of PKA, PKC, CAMKII, ERK 1/2 pathways is involved in the acute antidepressant-like effect of (octylseleno)-xylofuranoside (OSX) in mice.

Authors:  Lucimar M Pinto Brod; Mariana G Fronza; Jaqueline Pinto Vargas; Diogo S Lüdtke; César Augusto Brüning; Lucielli Savegnago
Journal:  Psychopharmacology (Berl)       Date:  2016-12-19       Impact factor: 4.530

6.  A postpartum model in rat: behavioral and gene expression changes induced by ovarian steroid deprivation.

Authors:  Shiro Suda; Eri Segi-Nishida; Samuel S Newton; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2008-05-08       Impact factor: 13.382

7.  Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients.

Authors:  Phil Ok Koh; Ashiwel S Undie; Nadine Kabbani; Robert Levenson; Patricia S Goldman-Rakic; Michael S Lidow
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-20       Impact factor: 11.205

Review 8.  Adult Neurogenesis and Psychiatric Disorders.

Authors:  Eunchai Kang; Zhexing Wen; Hongjun Song; Kimberly M Christian; Guo-Li Ming
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

9.  Canonical correlation analysis for RNA-seq co-expression networks.

Authors:  Shengjun Hong; Xiangning Chen; Li Jin; Momiao Xiong
Journal:  Nucleic Acids Res       Date:  2013-03-04       Impact factor: 16.971

10.  The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease.

Authors:  Rick Shin; Katsunori Kobayashi; Hideo Hagihara; Jeffrey H Kogan; Shinichi Miyake; Katsunori Tajinda; Noah M Walton; Adam K Gross; Carrie L Heusner; Qian Chen; Kouichi Tamura; Tsuyoshi Miyakawa; Mitsuyuki Matsumoto
Journal:  Bipolar Disord       Date:  2013-04-06       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.